Seek Returns logo

ABT vs. NFLX: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at ABT and NFLX, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Overview

NFLX’s market capitalization of 552.04 billion USD is significantly greater than ABT’s 233.90 billion USD, highlighting its more substantial market valuation.

NFLX carries a higher beta at 1.59, indicating it’s more sensitive to market moves, while ABT (beta: 0.74) exhibits greater stability.

SymbolABTNFLX
Company NameAbbott LaboratoriesNetflix, Inc.
CountryUSUS
SectorHealthcareCommunication Services
IndustryMedical - DevicesEntertainment
CEORobert B. FordTheodore A. Sarandos
Price134.44 USD1,297.18 USD
Market Cap233.90 billion USD552.04 billion USD
Beta0.741.59
ExchangeNYSENASDAQ
IPO DateMarch 17, 1980May 23, 2002
ADRNoNo

Historical Performance

This chart compares the performance of ABT and NFLX by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period.

Data is adjusted for dividends and splits.

ABT vs. NFLX: Growth of a $10,000 investment over the past one year.

Profitability

Return on Equity

ABT

30.76%

Medical - Devices Industry

Max
49.04%
Q3
9.53%
Median
-7.46%
Q1
-32.83%
Min
-82.64%

In the upper quartile for the Medical - Devices industry, ABT’s Return on Equity of 30.76% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

NFLX

39.61%

Entertainment Industry

Max
52.68%
Q3
19.21%
Median
2.19%
Q1
-9.02%
Min
-38.07%

In the upper quartile for the Entertainment industry, NFLX’s Return on Equity of 39.61% signals a highly effective use of shareholder capital to drive profitability compared to most of its peers.

ABT vs. NFLX: A comparison of their ROE against their respective Medical - Devices and Entertainment industry benchmarks.

Return on Invested Capital

ABT

19.13%

Medical - Devices Industry

Max
21.88%
Q3
6.63%
Median
-1.11%
Q1
-21.08%
Min
-51.95%

In the upper quartile for the Medical - Devices industry, ABT’s Return on Invested Capital of 19.13% signifies a highly effective use of its capital to generate profits when compared to its peers.

NFLX

22.23%

Entertainment Industry

Max
22.23%
Q3
7.94%
Median
4.38%
Q1
-1.64%
Min
-11.28%

In the upper quartile for the Entertainment industry, NFLX’s Return on Invested Capital of 22.23% signifies a highly effective use of its capital to generate profits when compared to its peers.

ABT vs. NFLX: A comparison of their ROIC against their respective Medical - Devices and Entertainment industry benchmarks.

Net Profit Margin

ABT

31.89%

Medical - Devices Industry

Max
44.80%
Q3
9.77%
Median
-5.53%
Q1
-29.37%
Min
-87.68%

A Net Profit Margin of 31.89% places ABT in the upper quartile for the Medical - Devices industry, signifying strong profitability and more effective cost management than most of its peers.

NFLX

23.09%

Entertainment Industry

Max
23.09%
Q3
7.10%
Median
4.00%
Q1
-5.55%
Min
-19.16%

A Net Profit Margin of 23.09% places NFLX in the upper quartile for the Entertainment industry, signifying strong profitability and more effective cost management than most of its peers.

ABT vs. NFLX: A comparison of their Net Profit Margin against their respective Medical - Devices and Entertainment industry benchmarks.

Operating Profit Margin

ABT

16.97%

Medical - Devices Industry

Max
30.13%
Q3
13.12%
Median
3.47%
Q1
-24.42%
Min
-80.56%

An Operating Profit Margin of 16.97% places ABT in the upper quartile for the Medical - Devices industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

NFLX

27.65%

Entertainment Industry

Max
27.65%
Q3
14.60%
Median
8.91%
Q1
-1.50%
Min
-17.48%

An Operating Profit Margin of 27.65% places NFLX in the upper quartile for the Entertainment industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

ABT vs. NFLX: A comparison of their Operating Margin against their respective Medical - Devices and Entertainment industry benchmarks.

Profitability at a Glance

SymbolABTNFLX
Return on Equity (TTM)30.76%39.61%
Return on Assets (TTM)16.58%17.80%
Return on Invested Capital (TTM)19.13%22.23%
Net Profit Margin (TTM)31.89%23.09%
Operating Profit Margin (TTM)16.97%27.65%
Gross Profit Margin (TTM)55.89%46.87%

Financial Strength

Current Ratio

ABT

1.78

Medical - Devices Industry

Max
12.68
Q3
6.30
Median
4.05
Q1
1.85
Min
0.01

ABT’s Current Ratio of 1.78 falls into the lower quartile for the Medical - Devices industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.

NFLX

1.20

Entertainment Industry

Max
2.86
Q3
1.51
Median
0.84
Q1
0.46
Min
0.26

NFLX’s Current Ratio of 1.20 aligns with the median group of the Entertainment industry, indicating that its short-term liquidity is in line with its sector peers.

ABT vs. NFLX: A comparison of their Current Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Debt-to-Equity Ratio

ABT

0.27

Medical - Devices Industry

Max
2.34
Q3
1.09
Median
0.37
Q1
0.08
Min
0.00

ABT’s Debt-to-Equity Ratio of 0.27 is typical for the Medical - Devices industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

NFLX

0.73

Entertainment Industry

Max
10.61
Q3
5.84
Median
0.94
Q1
0.71
Min
0.01

NFLX’s Debt-to-Equity Ratio of 0.73 is typical for the Entertainment industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.

ABT vs. NFLX: A comparison of their D/E Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Interest Coverage Ratio

ABT

15.39

Medical - Devices Industry

Max
18.18
Q3
7.53
Median
0.85
Q1
-9.80
Min
-33.94

ABT’s Interest Coverage Ratio of 15.39 is in the upper quartile for the Medical - Devices industry, signifying a strong and healthy capacity to meet its interest payments from operating profits.

NFLX

14.77

Entertainment Industry

Max
7.49
Q3
3.71
Median
1.58
Q1
-0.42
Min
-5.05

With an Interest Coverage Ratio of 14.77, NFLX demonstrates a superior capacity to service its debt, placing it well above the typical range for the Entertainment industry. This stems from either robust earnings or a conservative debt load.

ABT vs. NFLX: A comparison of their Interest Coverage against their respective Medical - Devices and Entertainment industry benchmarks.

Financial Strength at a Glance

SymbolABTNFLX
Current Ratio (TTM)1.781.20
Quick Ratio (TTM)1.271.20
Debt-to-Equity Ratio (TTM)0.270.73
Debt-to-Asset Ratio (TTM)0.160.33
Net Debt-to-EBITDA Ratio (TTM)0.600.38
Interest Coverage Ratio (TTM)15.3914.77

Growth

The following charts compare key year-over-year (YoY) growth metrics for ABT and NFLX. These metrics are based on the companies’ annual financial reports.

Revenue Growth

ABT vs. NFLX: A comparison of their annual year-over-year Revenue Growth.

Earnings Per Share (EPS) Growth

ABT vs. NFLX: A comparison of their annual year-over-year Earnings Per Share (EPS) Growth.

Free Cash Flow Growth

ABT vs. NFLX: A comparison of their annual year-over-year Free Cash Flow Growth.

Dividend

Dividend Yield

ABT

1.70%

Medical - Devices Industry

Max
3.57%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

With a Dividend Yield of 1.70%, ABT offers a more attractive income stream than most of its peers in the Medical - Devices industry, signaling a strong commitment to shareholder returns.

NFLX

0.00%

Entertainment Industry

Max
7.41%
Q3
0.95%
Median
0.00%
Q1
0.00%
Min
0.00%

NFLX currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

ABT vs. NFLX: A comparison of their Dividend Yield against their respective Medical - Devices and Entertainment industry benchmarks.

Dividend Payout Ratio

ABT

28.92%

Medical - Devices Industry

Max
102.12%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

ABT’s Dividend Payout Ratio of 28.92% is in the upper quartile for the Medical - Devices industry. This indicates a strong commitment to shareholder returns but also suggests that a smaller portion of earnings is retained for reinvestment compared to many peers.

NFLX

0.00%

Entertainment Industry

Max
82.73%
Q3
7.88%
Median
0.00%
Q1
0.00%
Min
0.00%

NFLX has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

ABT vs. NFLX: A comparison of their Payout Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Dividend at a Glance

SymbolABTNFLX
Dividend Yield (TTM)1.70%0.00%
Dividend Payout Ratio (TTM)28.92%0.00%

Valuation

Price-to-Earnings Ratio

ABT

17.40

Medical - Devices Industry

Max
90.56
Q3
56.92
Median
43.19
Q1
21.79
Min
5.55

In the lower quartile for the Medical - Devices industry, ABT’s P/E Ratio of 17.40 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

NFLX

59.79

Entertainment Industry

Max
85.23
Q3
70.18
Median
35.61
Q1
19.80
Min
6.95

NFLX’s P/E Ratio of 59.79 is within the middle range for the Entertainment industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

ABT vs. NFLX: A comparison of their P/E Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Forward P/E to Growth Ratio

ABT

1.73

Medical - Devices Industry

Max
6.56
Q3
3.52
Median
2.22
Q1
0.55
Min
0.03

ABT’s Forward PEG Ratio of 1.73 is within the middle range of its peers in the Medical - Devices industry. This suggests a reasonable balance between the stock’s price and its expected growth, aligning with sector valuation norms.

NFLX

3.36

Entertainment Industry

Max
5.10
Q3
2.63
Median
1.23
Q1
0.35
Min
0.06

A Forward PEG Ratio of 3.36 places NFLX in the upper quartile for the Entertainment industry. This suggests the stock is potentially expensive compared to its peers relative to its growth forecast, which may warrant caution.

ABT vs. NFLX: A comparison of their Forward PEG Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Price-to-Sales Ratio

ABT

5.52

Medical - Devices Industry

Max
15.74
Q3
8.12
Median
3.40
Q1
2.37
Min
0.42

ABT’s P/S Ratio of 5.52 aligns with the market consensus for the Medical - Devices industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

NFLX

13.75

Entertainment Industry

Max
4.71
Q3
2.84
Median
1.46
Q1
0.70
Min
0.27

With a P/S Ratio of 13.75, NFLX trades at a valuation that eclipses even the highest in the Entertainment industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

ABT vs. NFLX: A comparison of their P/S Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Price-to-Book Ratio

ABT

4.81

Medical - Devices Industry

Max
16.65
Q3
8.03
Median
3.73
Q1
1.92
Min
0.65

ABT’s P/B Ratio of 4.81 is within the conventional range for the Medical - Devices industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

NFLX

23.07

Entertainment Industry

Max
11.55
Q3
8.75
Median
2.23
Q1
1.18
Min
0.51

The P/B Ratio is often not a primary valuation metric for the Entertainment industry.

ABT vs. NFLX: A comparison of their P/B Ratio against their respective Medical - Devices and Entertainment industry benchmarks.

Valuation at a Glance

SymbolABTNFLX
Price-to-Earnings Ratio (P/E, TTM)17.4059.79
Forward PEG Ratio (TTM)1.733.36
Price-to-Sales Ratio (P/S, TTM)5.5213.75
Price-to-Book Ratio (P/B, TTM)4.8123.07
Price-to-Free Cash Flow Ratio (P/FCF, TTM)35.1474.14
EV-to-EBITDA (TTM)21.4921.07
EV-to-Sales (TTM)5.6814.01